ANTX Stock | | | USD 1.09 0.02 1.80% |
AN2 Therapeutics financial indicator trend analysis is way more than just evaluating AN2 Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AN2 Therapeutics is a good investment. Please check the relationship between AN2 Therapeutics Accounts Payable and its Total Assets accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy AN2 Stock please use our
How to Invest in AN2 Therapeutics guide.
Accounts Payable vs Total Assets
Accounts Payable vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
AN2 Therapeutics Accounts Payable account and
Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between AN2 Therapeutics' Accounts Payable and Total Assets is 0.93. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Assets in the same time period over historical financial statements of AN2 Therapeutics, assuming nothing else is changed. The correlation between historical values of AN2 Therapeutics' Accounts Payable and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of AN2 Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Accounts Payable i.e., AN2 Therapeutics' Accounts Payable and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.93 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Accounts Payable
An accounting item on the balance sheet that represents AN2 Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of AN2 Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Total Assets
Total assets refers to the total amount of AN2 Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AN2 Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from AN2 Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AN2 Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy AN2 Stock please use our
How to Invest in AN2 Therapeutics guide.At this time, AN2 Therapeutics'
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to rise to 100.21 in 2024, whereas
Selling General Administrative is likely to drop slightly above 7.7
M in 2024.
AN2 Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
AN2 Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to
measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to
predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.